{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T09:28:07Z","timestamp":1787563687611,"version":"build-2736575974"},"reference-count":200,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2025,10,24]],"date-time":"2025-10-24T00:00:00Z","timestamp":1761264000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,10,24]],"date-time":"2025-10-24T00:00:00Z","timestamp":1761264000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Polish Ministry of Science and Higher Education","award":["N43\/DBS\/000345"],"award-info":[{"award-number":["N43\/DBS\/000345"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pharmacol. Rep"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1007\/s43440-025-00796-5","type":"journal-article","created":{"date-parts":[[2025,10,24]],"date-time":"2025-10-24T07:07:44Z","timestamp":1761289664000},"page":"1468-1490","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["The role of microbiota modulation in preventing Alzheimer\u2019s disease- a review"],"prefix":"10.1007","volume":"77","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3841-2575","authenticated-orcid":false,"given":"Anna","family":"Strz\u0119pa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0388-2382","authenticated-orcid":false,"given":"Marian","family":"Szczepanik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,10,24]]},"reference":[{"issue":"6","key":"796_CR1","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1016\/j.jalz.2016.01.012","volume":"12","author":"R Cacace","year":"2016","unstructured":"Cacace R, Sleegers K, Van Broeckhoven C. Molecular genetics of early-onset Alzheimer\u2019s disease revisited. Alzheimers Dement. 2016;12(6):733\u201348.","journal-title":"Alzheimers Dement"},{"key":"796_CR2","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.conb.2019.11.024","volume":"61","author":"C Bellenguez","year":"2020","unstructured":"Bellenguez C, Grenier-Boley B, Lambert JC. Genetics of Alzheimer\u2019s disease: where we are, and where we are going. Curr Opin Neurobiol. 2020;61:40\u20138.","journal-title":"Curr Opin Neurobiol"},{"issue":"5054","key":"796_CR3","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1126\/science.1566067","volume":"256","author":"JA Hardy","year":"1992","unstructured":"Hardy JA, Higgins GA. Alzheimer\u2019s disease: the amyloid cascade hypothesis. Science. 1992;256(5054):184\u20135.","journal-title":"Science"},{"issue":"3","key":"796_CR4","doi-asserted-by":"publisher","first-page":"1065","DOI":"10.3233\/JAD-150852","volume":"52","author":"C Henneges","year":"2016","unstructured":"Henneges C, Reed C, Chen YF, Dell\u2019Agnello G, Lebrec J. Describing the sequence of cognitive decline in Alzheimer\u2019s disease patients: results from an observational study. J Alzheimers Dis. 2016;52(3):1065\u201380.","journal-title":"J Alzheimers Dis"},{"issue":"2","key":"796_CR5","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1037\/pag0000236","volume":"33","author":"JE Karr","year":"2018","unstructured":"Karr JE, Graham RB, Hofer SM, Muniz-Terrera G. When does cognitive decline begin? A systematic review of change point studies on accelerated decline in cognitive and neurological outcomes preceding mild cognitive impairment, dementia, and death. Psychol Aging. 2018;33(2):195\u2013218.","journal-title":"Psychol Aging"},{"issue":"2","key":"796_CR6","doi-asserted-by":"publisher","first-page":"e105","DOI":"10.1016\/S2468-2667(21)00249-8","volume":"7","author":"GBDDF Collaborators","year":"2022","unstructured":"Collaborators GBDDF. Estimation of the global prevalence of dementia in 2019 and forecasted prevalence in 2050: an analysis for the global burden of disease study 2019. Lancet Public Health. 2022;7(2):e105\u201325.","journal-title":"Lancet Public Health"},{"issue":"4","key":"796_CR7","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1016\/S1474-4422(24)00038-3","volume":"23","author":"GBDNSD Collaborators","year":"2024","unstructured":"Collaborators GBDNSD. Global, regional, and National burden of disorders affecting the nervous system, 1990\u20132021: a systematic analysis for the global burden of disease study 2021. Lancet Neurol. 2024;23(4):344\u201381.","journal-title":"Lancet Neurol"},{"key":"796_CR8","doi-asserted-by":"publisher","first-page":"1474043","DOI":"10.3389\/fmed.2024.1474043","volume":"11","author":"S Safiri","year":"2024","unstructured":"Safiri S, Ghaffari Jolfayi A, Fazlollahi A, Morsali S, Sarkesh A, Daei Sorkhabi A, et al. Alzheimer\u2019s disease: a comprehensive review of epidemiology, risk factors, symptoms diagnosis, management, caregiving, advanced treatments and associated challenges. Front Med (Lausanne). 2024;11:1474043.","journal-title":"Front Med (Lausanne)"},{"issue":"1","key":"796_CR9","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1038\/s41392-024-01911-3","volume":"9","author":"J Zhang","year":"2024","unstructured":"Zhang J, Zhang Y, Wang J, Xia Y, Zhang J, Chen L. Recent advances in Alzheimer\u2019s disease: Mechanisms, clinical trials and new drug development strategies. Signal Transduct Target Ther. 2024;9(1):211.","journal-title":"Signal Transduct Target Ther"},{"issue":"36","key":"796_CR10","doi-asserted-by":"publisher","first-page":"44659","DOI":"10.1007\/s11356-020-08243-z","volume":"27","author":"MA Rahman","year":"2020","unstructured":"Rahman MA, Rahman MS, Uddin MJ, Mamum-Or-Rashid ANM, Pang MG, Rhim H. Emerging risk of environmental factors: insight mechanisms of Alzheimer\u2019s diseases. Environ Sci Pollut Res Int. 2020;27(36):44659\u201372.","journal-title":"Environ Sci Pollut Res Int"},{"issue":"12","key":"796_CR11","doi-asserted-by":"publisher","first-page":"1452","DOI":"10.1038\/ng.2802","volume":"45","author":"JC Lambert","year":"2013","unstructured":"Lambert JC, Ibrahim-Verbaas CA, Harold D, Naj AC, Sims R, Bellenguez C, et al. Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer\u2019s disease. Nat Genet. 2013;45(12):1452\u20138.","journal-title":"Nat Genet"},{"issue":"18","key":"796_CR12","doi-asserted-by":"publisher","first-page":"1832","DOI":"10.1001\/jama.2010.574","volume":"303","author":"S Seshadri","year":"2010","unstructured":"Seshadri S, Fitzpatrick AL, Ikram MA, DeStefano AL, Gudnason V, Boada M, et al. Genome-wide analysis of genetic loci associated with Alzheimer disease. JAMA. 2010;303(18):1832\u201340.","journal-title":"JAMA"},{"issue":"1","key":"796_CR13","doi-asserted-by":"publisher","first-page":"13537","DOI":"10.1038\/s41598-017-13601-y","volume":"7","author":"NM Vogt","year":"2017","unstructured":"Vogt NM, Kerby RL, Dill-McFarland KA, Harding SJ, Merluzzi AP, Johnson SC, et al. Gut Microbiome alterations in Alzheimer\u2019s disease. Sci Rep. 2017;7(1):13537.","journal-title":"Sci Rep"},{"issue":"4","key":"796_CR14","doi-asserted-by":"publisher","first-page":"1337","DOI":"10.3233\/JAD-180176","volume":"63","author":"ZQ Zhuang","year":"2018","unstructured":"Zhuang ZQ, Shen LL, Li WW, Fu X, Zeng F, Gui L, et al. Gut microbiota is altered in patients with Alzheimer\u2019s disease. J Alzheimers Dis. 2018;63(4):1337\u201346.","journal-title":"J Alzheimers Dis"},{"issue":"7","key":"796_CR15","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1038\/sj.embor.7400731","volume":"7","author":"AM O\u2019Hara","year":"2006","unstructured":"O\u2019Hara AM, Shanahan F. The gut flora as a forgotten organ. EMBO Rep. 2006;7(7):688\u201393.","journal-title":"EMBO Rep"},{"issue":"3","key":"796_CR16","doi-asserted-by":"publisher","first-page":"980","DOI":"10.1002\/alz.12714","volume":"19","author":"R Batra","year":"2023","unstructured":"Batra R, Arnold M, Worheide MA, Allen M, Wang X, Blach C, et al. The landscape of metabolic brain alterations in Alzheimer\u2019s disease. Alzheimers Dement. 2023;19(3):980\u201398.","journal-title":"Alzheimers Dement"},{"issue":"19","key":"796_CR17","doi-asserted-by":"publisher","first-page":"1672","DOI":"10.1212\/01.wnl.0000311269.57716.63","volume":"70","author":"SC Vlad","year":"2008","unstructured":"Vlad SC, Miller DR, Kowall NW, Felson DT. Protective effects of NSAIDs on the development of Alzheimer disease. Neurology. 2008;70(19):1672\u20137.","journal-title":"Neurology"},{"key":"796_CR18","doi-asserted-by":"crossref","unstructured":"Elangovan S, Borody TJ, Holsinger RMD. Fecal Microbiota Transplantation Reduces Pathology and Improves Cognition in a Mouse Model of Alzheimer\u2019s Disease. Cells. 2022;12(1).","DOI":"10.3390\/cells12010119"},{"issue":"4","key":"796_CR19","doi-asserted-by":"publisher","first-page":"589","DOI":"10.5056\/jnm16018","volume":"22","author":"H Wang","year":"2016","unstructured":"Wang H, Lee IS, Braun C, Enck P. Effect of probiotics on central nervous system functions in animals and humans: A systematic review. J Neurogastroenterol Motil. 2016;22(4):589\u2013605.","journal-title":"J Neurogastroenterol Motil"},{"issue":"1","key":"796_CR20","doi-asserted-by":"publisher","first-page":"e210129","DOI":"10.1212\/WNL.0000000000210129","volume":"104","author":"Y Wang","year":"2025","unstructured":"Wang Y, Zhou Z, Broder JC, Woods RL, Orchard SG, Wolfe R, et al. Antibiotic use and subsequent cognitive decline and dementia risk in healthy older adults. Neurology. 2025;104(1):e210129.","journal-title":"Neurology"},{"issue":"6","key":"796_CR21","doi-asserted-by":"publisher","first-page":"912","DOI":"10.1002\/ana.20854","volume":"59","author":"N Scarmeas","year":"2006","unstructured":"Scarmeas N, Stern Y, Tang MX, Mayeux R, Luchsinger JA. Mediterranean diet and risk for Alzheimer\u2019s disease. Ann Neurol. 2006;59(6):912\u201321.","journal-title":"Ann Neurol"},{"issue":"4","key":"796_CR22","doi-asserted-by":"publisher","first-page":"590","DOI":"10.1097\/00004728-198308000-00003","volume":"7","author":"RP Friedland","year":"1983","unstructured":"Friedland RP, Budinger TF, Ganz E, Yano Y, Mathis CA, Koss B, et al. Regional cerebral metabolic alterations in dementia of the Alzheimer type: positron emission tomography with [18F]fluorodeoxyglucose. J Comput Assist Tomogr. 1983;7(4):590\u20138.","journal-title":"J Comput Assist Tomogr"},{"issue":"1","key":"796_CR23","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1186\/s13195-021-00783-x","volume":"13","author":"MCL Phillips","year":"2021","unstructured":"Phillips MCL, Deprez LM, Mortimer GMN, Murtagh DKJ, McCoy S, Mylchreest R, et al. Randomized crossover trial of a modified ketogenic diet in Alzheimer\u2019s disease. Alzheimers Res Ther. 2021;13(1):51.","journal-title":"Alzheimers Res Ther"},{"key":"796_CR24","doi-asserted-by":"publisher","first-page":"937486","DOI":"10.3389\/fnagi.2022.937486","volume":"14","author":"X Li","year":"2022","unstructured":"Li X, Feng X, Sun X, Hou N, Han F, Liu Y. Global, regional, and National burden of Alzheimer\u2019s disease and other dementias, 1990\u20132019. Front Aging Neurosci. 2022;14:937486.","journal-title":"Front Aging Neurosci"},{"issue":"6311","key":"796_CR25","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1038\/349704a0","volume":"349","author":"A Goate","year":"1991","unstructured":"Goate A, Chartier-Harlin MC, Mullan M, Brown J, Crawford F, Fidani L, et al. Segregation of a missense mutation in the amyloid precursor protein gene with Familial Alzheimer\u2019s disease. Nature. 1991;349(6311):704\u20136.","journal-title":"Nature"},{"issue":"1","key":"796_CR26","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1002\/ana.410230106","volume":"23","author":"TD Bird","year":"1988","unstructured":"Bird TD, Lampe TH, Nemens EJ, Miner GW, Sumi SM, Schellenberg GD. Familial Alzheimer\u2019s disease in American descendants of the Volga germans: probable genetic founder effect. Ann Neurol. 1988;23(1):25\u201331.","journal-title":"Ann Neurol"},{"issue":"6534","key":"796_CR27","doi-asserted-by":"publisher","first-page":"754","DOI":"10.1038\/375754a0","volume":"375","author":"R Sherrington","year":"1995","unstructured":"Sherrington R, Rogaev EI, Liang Y, Rogaeva EA, Levesque G, Ikeda M, et al. Cloning of a gene bearing missense mutations in early-onset Familial Alzheimer\u2019s disease. Nature. 1995;375(6534):754\u201360.","journal-title":"Nature"},{"issue":"5123","key":"796_CR28","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1126\/science.8346443","volume":"261","author":"EH Corder","year":"1993","unstructured":"Corder EH, Saunders AM, Strittmatter WJ, Schmechel DE, Gaskell PC, Small GW, et al. Gene dose of Apolipoprotein E type 4 allele and the risk of Alzheimer\u2019s disease in late onset families. Science. 1993;261(5123):921\u20133.","journal-title":"Science"},{"key":"796_CR29","doi-asserted-by":"crossref","unstructured":"Penke B, Bogar F, Fulop L. beta-Amyloid and the Pathomechanisms of Alzheimer\u2019s Disease: A Comprehensive View. Molecules. 2017;22(10).","DOI":"10.3390\/molecules22101692"},{"issue":"2","key":"796_CR30","doi-asserted-by":"publisher","first-page":"303","DOI":"10.3233\/JAD-170061","volume":"58","author":"XZ Yuan","year":"2017","unstructured":"Yuan XZ, Sun S, Tan CC, Yu JT, Tan L. The role of ADAM10 in Alzheimer\u2019s disease. J Alzheimers Dis. 2017;58(2):303\u201322.","journal-title":"J Alzheimers Dis"},{"key":"796_CR31","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1146\/annurev-biochem-061516-045115","volume":"86","author":"F Chiti","year":"2017","unstructured":"Chiti F, Dobson CM. Protein Misfolding, amyloid Formation, and human disease: A summary of progress over the last decade. Annu Rev Biochem. 2017;86:27\u201368.","journal-title":"Annu Rev Biochem"},{"issue":"14","key":"796_CR32","doi-asserted-by":"publisher","first-page":"5819","DOI":"10.1073\/pnas.1017033108","volume":"108","author":"M Jin","year":"2011","unstructured":"Jin M, Shepardson N, Yang T, Chen G, Walsh D, Selkoe DJ. Soluble amyloid beta-protein dimers isolated from Alzheimer cortex directly induce Tau hyperphosphorylation and neuritic degeneration. Proc Natl Acad Sci U S A. 2011;108(14):5819\u201324.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"796_CR33","doi-asserted-by":"publisher","first-page":"21","DOI":"10.3390\/ijms232112841","volume":"23","author":"P Rawat","year":"2022","unstructured":"Rawat P, Sehar U, Bisht J, Selman A, Culberson J, Reddy PH. Phosphorylated Tau in Alzheimer\u2019s disease and other tauopathies. Int J Mol Sci. 2022;23:21.","journal-title":"Int J Mol Sci"},{"issue":"3 Pt 1","key":"796_CR34","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1212\/WNL.42.3.631","volume":"42","author":"PV Arriagada","year":"1992","unstructured":"Arriagada PV, Growdon JH, Hedley-Whyte ET, Hyman BT. Neurofibrillary tangles but not senile plaques parallel duration and severity of Alzheimer\u2019s disease. Neurology. 1992;42(3 Pt 1):631\u20139.","journal-title":"Neurology"},{"issue":"1","key":"796_CR35","doi-asserted-by":"publisher","first-page":"19","DOI":"10.2174\/1389203043486937","volume":"5","author":"Y Verdier","year":"2004","unstructured":"Verdier Y, Penke B. Binding sites of amyloid beta-peptide in cell plasma membrane and implications for Alzheimer\u2019s disease. Curr Protein Pept Sci. 2004;5(1):19\u201331.","journal-title":"Curr Protein Pept Sci"},{"issue":"2","key":"796_CR36","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1016\/j.bbrc.2016.09.073","volume":"479","author":"M Go","year":"2016","unstructured":"Go M, Kou J, Lim JE, Yang J, Fukuchi KI. Microglial response to LPS increases in wild-type mice during aging but diminishes in an Alzheimer\u2019s mouse model: implication of TLR4 signaling in disease progression. Biochem Biophys Res Commun. 2016;479(2):331\u20137.","journal-title":"Biochem Biophys Res Commun"},{"issue":"10","key":"796_CR37","doi-asserted-by":"publisher","first-page":"975","DOI":"10.1097\/NEN.0000000000000241","volume":"74","author":"I Lopez-Gonzalez","year":"2015","unstructured":"Lopez-Gonzalez I, Aso E, Carmona M, Armand-Ugon M, Blanco R, Naudi A, et al. Neuroinflammatory gene Regulation, mitochondrial Function, oxidative Stress, and brain lipid modifications with disease progression in Tau P301S Transgenic mice as a model of frontotemporal Lobar Degeneration-Tau. J Neuropathol Exp Neurol. 2015;74(10):975\u201399.","journal-title":"J Neuropathol Exp Neurol"},{"issue":"9","key":"796_CR38","doi-asserted-by":"publisher","first-page":"3240","DOI":"10.1172\/JCI90606","volume":"127","author":"H Sarlus","year":"2017","unstructured":"Sarlus H, Heneka MT. Microglia in Alzheimer\u2019s disease. J Clin Invest. 2017;127(9):3240\u20139.","journal-title":"J Clin Invest"},{"issue":"1","key":"796_CR39","first-page":"307","volume":"152","author":"SA Frautschy","year":"1998","unstructured":"Frautschy SA, Yang F, Irrizarry M, Hyman B, Saido TC, Hsiao K, et al. Microglial response to amyloid plaques in APPsw Transgenic mice. Am J Pathol. 1998;152(1):307\u201317.","journal-title":"Am J Pathol"},{"issue":"8","key":"796_CR40","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1038\/nn.4338","volume":"19","author":"RM Ransohoff","year":"2016","unstructured":"Ransohoff RM. A polarizing question: do M1 and M2 microglia exist? Nat Neurosci. 2016;19(8):987\u201391.","journal-title":"Nat Neurosci"},{"key":"796_CR41","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1146\/annurev.neuro.051508.135600","volume":"32","author":"A Kriegstein","year":"2009","unstructured":"Kriegstein A, Alvarez-Buylla A. The glial nature of embryonic and adult neural stem cells. Annu Rev Neurosci. 2009;32:149\u201384.","journal-title":"Annu Rev Neurosci"},{"issue":"20","key":"796_CR42","doi-asserted-by":"publisher","first-page":"4386","DOI":"10.1016\/j.cell.2023.08.037","volume":"186","author":"N Sun","year":"2023","unstructured":"Sun N, Victor MB, Park YP, Xiong X, Scannail AN, Leary N, et al. Human microglial state dynamics in Alzheimer\u2019s disease progression. Cell. 2023;186(20):4386\u2013403. e29.","journal-title":"Cell"},{"issue":"8","key":"796_CR43","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1093\/jnen\/60.8.759","volume":"60","author":"A Nunomura","year":"2001","unstructured":"Nunomura A, Perry G, Aliev G, Hirai K, Takeda A, Balraj EK, et al. Oxidative damage is the earliest event in Alzheimer disease. J Neuropathol Exp Neurol. 2001;60(8):759\u201367.","journal-title":"J Neuropathol Exp Neurol"},{"issue":"1","key":"796_CR44","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1002\/hbm.24799","volume":"41","author":"D Shukla","year":"2020","unstructured":"Shukla D, Mandal PK, Tripathi M, Vishwakarma G, Mishra R, Sandal K. Quantitation of in vivo brain glutathione conformers in cingulate cortex among age-matched control, MCI, and AD patients using MEGA-PRESS. Hum Brain Mapp. 2020;41(1):194\u2013217.","journal-title":"Hum Brain Mapp"},{"issue":"7","key":"796_CR45","doi-asserted-by":"publisher","first-page":"1627","DOI":"10.1007\/s11011-021-00765-w","volume":"36","author":"N Das","year":"2021","unstructured":"Das N, Raymick J, Sarkar S. Role of metals in Alzheimer\u2019s disease. Metab Brain Dis. 2021;36(7):1627\u201339.","journal-title":"Metab Brain Dis"},{"issue":"5","key":"796_CR46","doi-asserted-by":"publisher","first-page":"4379","DOI":"10.3390\/cimb46050266","volume":"46","author":"JP Hickey","year":"2024","unstructured":"Hickey JP, Collins AE, Nelson ML, Chen H, Kalisch BE. Modulation of oxidative stress and neuroinflammation by Cannabidiol (CBD): promising targets for the treatment of Alzheimer\u2019s disease. Curr Issues Mol Biol. 2024;46(5):4379\u2013402.","journal-title":"Curr Issues Mol Biol"},{"issue":"1","key":"796_CR47","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1186\/s13024-020-00376-6","volume":"15","author":"W Wang","year":"2020","unstructured":"Wang W, Zhao F, Ma X, Perry G, Zhu X. Mitochondria dysfunction in the pathogenesis of Alzheimer\u2019s disease: recent advances. Mol Neurodegener. 2020;15(1):30.","journal-title":"Mol Neurodegener"},{"issue":"28","key":"796_CR48","doi-asserted-by":"publisher","first-page":"9090","DOI":"10.1523\/JNEUROSCI.1357-09.2009","volume":"29","author":"X Wang","year":"2009","unstructured":"Wang X, Su B, Lee HG, Li X, Perry G, Smith MA, et al. Impaired balance of mitochondrial fission and fusion in Alzheimer\u2019s disease. J Neurosci. 2009;29(28):9090\u2013103.","journal-title":"J Neurosci"},{"issue":"5","key":"796_CR49","doi-asserted-by":"publisher","first-page":"738","DOI":"10.1176\/appi.ajp.159.5.738","volume":"159","author":"GE Alexander","year":"2002","unstructured":"Alexander GE, Chen K, Pietrini P, Rapoport SI, Reiman EM. Longitudinal PET evaluation of cerebral metabolic decline in dementia: A potential outcome measure in Alzheimer\u2019s disease treatment studies. Am J Psychiatry. 2002;159(5):738\u201345.","journal-title":"Am J Psychiatry"},{"issue":"5","key":"796_CR50","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1002\/ana.410350507","volume":"35","author":"IA Simpson","year":"1994","unstructured":"Simpson IA, Chundu KR, Davies-Hill T, Honer WG, Davies P. Decreased concentrations of GLUT1 and GLUT3 glucose transporters in the brains of patients with Alzheimer\u2019s disease. Ann Neurol. 1994;35(5):546\u201351.","journal-title":"Ann Neurol"},{"issue":"4\u20135","key":"796_CR51","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1007\/s007020050068","volume":"105","author":"L Frolich","year":"1998","unstructured":"Frolich L, Blum-Degen D, Bernstein HG, Engelsberger S, Humrich J, Laufer S, et al. Brain insulin and insulin receptors in aging and sporadic Alzheimer\u2019s disease. J Neural Transm (Vienna). 1998;105(4\u20135):423\u201338.","journal-title":"J Neural Transm (Vienna)"},{"issue":"4","key":"796_CR52","doi-asserted-by":"publisher","first-page":"1316","DOI":"10.1172\/JCI59903","volume":"122","author":"K Talbot","year":"2012","unstructured":"Talbot K, Wang HY, Kazi H, Han LY, Bakshi KP, Stucky A, et al. Demonstrated brain insulin resistance in Alzheimer\u2019s disease patients is associated with IGF-1 resistance, IRS-1 dysregulation, and cognitive decline. J Clin Invest. 2012;122(4):1316\u201338.","journal-title":"J Clin Invest"},{"issue":"8","key":"796_CR53","doi-asserted-by":"publisher","first-page":"1686","DOI":"10.1111\/j.1582-4934.2011.01441.x","volume":"16","author":"M Hashimoto","year":"2012","unstructured":"Hashimoto M, Bogdanovic N, Nakagawa H, Volkmann I, Aoki M, Winblad B, et al. Analysis of microdissected neurons by 18O mass spectrometry reveals altered protein expression in Alzheimer\u2019s disease. J Cell Mol Med. 2012;16(8):1686\u2013700.","journal-title":"J Cell Mol Med"},{"issue":"5","key":"796_CR54","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1016\/j.mito.2007.06.001","volume":"7","author":"H Atamna","year":"2007","unstructured":"Atamna H, Frey WH 2. Mechanisms of mitochondrial dysfunction and energy deficiency in Alzheimer\u2019s disease. Mitochondrion. 2007;7(5):297\u2013310.","journal-title":"Mitochondrion"},{"issue":"3","key":"796_CR55","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1001\/2013.jamaneurol.286","volume":"70","author":"HD Protas","year":"2013","unstructured":"Protas HD, Chen K, Langbaum JB, Fleisher AS, Alexander GE, Lee W, et al. Posterior cingulate glucose metabolism, hippocampal glucose metabolism, and hippocampal volume in cognitively normal, late-middle-aged persons at 3 levels of genetic risk for Alzheimer disease. JAMA Neurol. 2013;70(3):320\u20135.","journal-title":"JAMA Neurol"},{"issue":"3","key":"796_CR56","doi-asserted-by":"publisher","first-page":"323","DOI":"10.3233\/JAD-2008-13309","volume":"13","author":"MA Reger","year":"2008","unstructured":"Reger MA, Watson GS, Green PS, Baker LD, Cholerton B, Fishel MA, et al. Intranasal insulin administration dose-dependently modulates verbal memory and plasma amyloid-beta in memory-impaired older adults. J Alzheimers Dis. 2008;13(3):323\u201331.","journal-title":"J Alzheimers Dis"},{"key":"796_CR57","doi-asserted-by":"publisher","first-page":"108719","DOI":"10.1016\/j.neuropharm.2021.108719","volume":"196","author":"JV Andersen","year":"2021","unstructured":"Andersen JV, Markussen KH, Jakobsen E, Schousboe A, Waagepetersen HS, Rosenberg PA, et al. Glutamate metabolism and recycling at the excitatory synapse in health and neurodegeneration. Neuropharmacology. 2021;196:108719.","journal-title":"Neuropharmacology"},{"issue":"1\u20132","key":"796_CR58","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1016\/0006-8993(90)90030-F","volume":"536","author":"JK Blusztajn","year":"1990","unstructured":"Blusztajn JK, Lopez Gonzalez-Coviella I, Logue M, Growdon JH, Wurtman RJ. Levels of phospholipid catabolic intermediates, Glycerophosphocholine and glycerophosphoethanolamine, are elevated in brains of Alzheimer\u2019s disease but not of down\u2019s syndrome patients. Brain Res. 1990;536(1\u20132):240\u20134.","journal-title":"Brain Res"},{"issue":"7","key":"796_CR59","doi-asserted-by":"publisher","first-page":"2070","DOI":"10.1073\/pnas.0305799101","volume":"101","author":"RG Cutler","year":"2004","unstructured":"Cutler RG, Kelly J, Storie K, Pedersen WA, Tammara A, Hatanpaa K, et al. Involvement of oxidative stress-induced abnormalities in ceramide and cholesterol metabolism in brain aging and Alzheimer\u2019s disease. Proc Natl Acad Sci U S A. 2004;101(7):2070\u20135.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"8","key":"796_CR60","doi-asserted-by":"publisher","first-page":"1991","DOI":"10.1016\/j.bbamem.2007.02.014","volume":"1768","author":"EG Zinser","year":"2007","unstructured":"Zinser EG, Hartmann T, Grimm MO. Amyloid beta-protein and lipid metabolism. Biochim Biophys Acta. 2007;1768(8):1991\u20132001.","journal-title":"Biochim Biophys Acta"},{"issue":"7","key":"796_CR61","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1097\/00005072-199907000-00008","volume":"58","author":"Z Guan","year":"1999","unstructured":"Guan Z, Wang Y, Cairns NJ, Lantos PL, Dallner G, Sindelar PJ. Decrease and structural modifications of phosphatidylethanolamine plasmalogen in the brain with Alzheimer disease. J Neuropathol Exp Neurol. 1999;58(7):740\u20137.","journal-title":"J Neuropathol Exp Neurol"},{"key":"796_CR62","doi-asserted-by":"crossref","unstructured":"Mett J. The Impact of Medium Chain and Polyunsaturated omega-3-Fatty Acids on Amyloid-beta Deposition, Oxidative Stress and Metabolic Dysfunction Associated with Alzheimer\u2019s Disease. Antioxid (Basel). 2021;10(12).","DOI":"10.3390\/antiox10121991"},{"key":"796_CR63","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1016\/j.intimp.2018.10.021","volume":"65","author":"A Strzepa","year":"2018","unstructured":"Strzepa A, Lobo FM, Majewska-Szczepanik M, Szczepanik M. Antibiotics and autoimmune and allergy diseases: causative factor or treatment? Int Immunopharmacol. 2018;65:328\u201341.","journal-title":"Int Immunopharmacol"},{"key":"796_CR64","doi-asserted-by":"publisher","first-page":"1162057","DOI":"10.3389\/fnagi.2023.1162057","volume":"15","author":"KC Fan","year":"2023","unstructured":"Fan KC, Lin CC, Liu YC, Chao YP, Lai YJ, Chiu YL, et al. Altered gut microbiota in older adults with mild cognitive impairment: a case-control study. Front Aging Neurosci. 2023;15:1162057.","journal-title":"Front Aging Neurosci"},{"key":"796_CR65","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/j.neurobiolaging.2016.08.019","volume":"49","author":"A Cattaneo","year":"2017","unstructured":"Cattaneo A, Cattane N, Galluzzi S, Provasi S, Lopizzo N, Festari C, et al. Association of brain amyloidosis with pro-inflammatory gut bacterial taxa and peripheral inflammation markers in cognitively impaired elderly. Neurobiol Aging. 2017;49:60\u20138.","journal-title":"Neurobiol Aging"},{"key":"796_CR66","doi-asserted-by":"publisher","first-page":"794519","DOI":"10.3389\/fimmu.2021.794519","volume":"12","author":"BJH Verhaar","year":"2021","unstructured":"Verhaar BJH, Hendriksen HMA, de Leeuw FA, Doorduijn AS, van Leeuwenstijn M, Teunissen CE, et al. Gut microbiota composition is related to AD pathology. Front Immunol. 2021;12:794519.","journal-title":"Front Immunol"},{"issue":"22","key":"796_CR67","doi-asserted-by":"publisher","first-page":"2324","DOI":"10.1212\/WNL.0000000000003391","volume":"87","author":"X Zhan","year":"2016","unstructured":"Zhan X, Stamova B, Jin LW, DeCarli C, Phinney B, Sharp FR. Gram-negative bacterial molecules associate with Alzheimer disease pathology. Neurology. 2016;87(22):2324\u201332.","journal-title":"Neurology"},{"key":"796_CR68","doi-asserted-by":"publisher","first-page":"195","DOI":"10.3389\/fnagi.2017.00195","volume":"9","author":"DC Emery","year":"2017","unstructured":"Emery DC, Shoemark DK, Batstone TE, Waterfall CM, Coghill JA, Cerajewska TL, et al. 16S rRNA next generation sequencing analysis shows bacteria in Alzheimer\u2019s Post-Mortem brain. Front Aging Neurosci. 2017;9:195.","journal-title":"Front Aging Neurosci"},{"issue":"8","key":"796_CR69","doi-asserted-by":"publisher","first-page":"1556","DOI":"10.1111\/j.1532-5415.2012.04064.x","volume":"60","author":"A Paganini-Hill","year":"2012","unstructured":"Paganini-Hill A, White SC, Atchison KA. Dentition, dental health habits, and dementia: the leisure world cohort study. J Am Geriatr Soc. 2012;60(8):1556\u201363.","journal-title":"J Am Geriatr Soc"},{"issue":"1","key":"796_CR70","doi-asserted-by":"publisher","first-page":"eaau3333","DOI":"10.1126\/sciadv.aau3333","volume":"5","author":"SS Dominy","year":"2019","unstructured":"Dominy SS, Lynch C, Ermini F, Benedyk M, Marczyk A, Konradi A, et al. Porphyromonas gingivalis in Alzheimer\u2019s disease brains: evidence for disease causation and treatment with small-molecule inhibitors. Sci Adv. 2019;5(1):eaau3333.","journal-title":"Sci Adv"},{"issue":"4","key":"796_CR71","doi-asserted-by":"publisher","first-page":"1241","DOI":"10.3233\/JAD-170020","volume":"60","author":"L Zhang","year":"2017","unstructured":"Zhang L, Wang Y, Xiayu X, Shi C, Chen W, Song N, et al. Altered gut microbiota in a mouse model of Alzheimer\u2019s disease. J Alzheimers Dis. 2017;60(4):1241\u201357.","journal-title":"J Alzheimers Dis"},{"issue":"2","key":"796_CR72","doi-asserted-by":"publisher","first-page":"775","DOI":"10.3233\/JAD-160926","volume":"56","author":"C Brandscheid","year":"2017","unstructured":"Brandscheid C, Schuck F, Reinhardt S, Schafer KH, Pietrzik CU, Grimm M, et al. Altered gut Microbiome composition and tryptic activity of the 5xFAD Alzheimer\u2019s mouse model. J Alzheimers Dis. 2017;56(2):775\u201388.","journal-title":"J Alzheimers Dis"},{"issue":"11","key":"796_CR73","doi-asserted-by":"publisher","first-page":"2233","DOI":"10.1136\/gutjnl-2021-326269","volume":"71","author":"C Chen","year":"2022","unstructured":"Chen C, Liao J, Xia Y, Liu X, Jones R, Haran J, et al. Gut microbiota regulate Alzheimer\u2019s disease pathologies and cognitive disorders via PUFA-associated neuroinflammation. Gut. 2022;71(11):2233\u201352.","journal-title":"Gut"},{"issue":"7415","key":"796_CR74","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1038\/nature11550","volume":"489","author":"CA Lozupone","year":"2012","unstructured":"Lozupone CA, Stombaugh JI, Gordon JI, Jansson JK, Knight R. Diversity, stability and resilience of the human gut microbiota. Nature. 2012;489(7415):220\u201330.","journal-title":"Nature"},{"key":"796_CR75","doi-asserted-by":"crossref","unstructured":"Wu L, Han Y, Zheng Z, Peng G, Liu P, Yue S et al. Altered Gut Microbial Metabolites in Amnestic Mild Cognitive Impairment and Alzheimer\u2019s Disease: Signals in Host-Microbe Interplay. Nutrients. 2021;13(1).","DOI":"10.3390\/nu13010228"},{"issue":"11","key":"796_CR76","doi-asserted-by":"publisher","first-page":"3657","DOI":"10.1111\/cns.14252","volume":"29","author":"C Gao","year":"2023","unstructured":"Gao C, Li B, He Y, Huang P, Du J, He G, et al. Early changes of fecal short-chain fatty acid levels in patients with mild cognitive impairments. CNS Neurosci Ther. 2023;29(11):3657\u201366.","journal-title":"CNS Neurosci Ther"},{"issue":"4","key":"796_CR77","doi-asserted-by":"publisher","first-page":"e12768","DOI":"10.1111\/acel.12768","volume":"17","author":"D Li","year":"2018","unstructured":"Li D, Ke Y, Zhan R, Liu C, Zhao M, Zeng A, et al. Trimethylamine-N-oxide promotes brain aging and cognitive impairment in mice. Aging Cell. 2018;17(4):e12768.","journal-title":"Aging Cell"},{"key":"796_CR78","doi-asserted-by":"crossref","unstructured":"Del Rio D, Zimetti F, Caffarra P, Tassotti M, Bernini F, Brighenti F et al. The gut microbial metabolite Trimethylamine-N-Oxide is present in human cerebrospinal fluid. Nutrients. 2017;9(10).","DOI":"10.3390\/nu9101053"},{"issue":"1","key":"796_CR79","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1186\/s13195-024-01480-1","volume":"16","author":"A Yaqub","year":"2024","unstructured":"Yaqub A, Vojinovic D, Vernooij MW, Slagboom PE, Ghanbari M, Beekman M, et al. Plasma trimethylamine N-oxide (TMAO): associations with cognition, neuroimaging, and dementia. Alzheimers Res Ther. 2024;16(1):113.","journal-title":"Alzheimers Res Ther"},{"issue":"10","key":"796_CR80","doi-asserted-by":"publisher","first-page":"e70091","DOI":"10.1111\/cns.70091","volume":"30","author":"J Yang","year":"2024","unstructured":"Yang J, Liang J, Hu N, He N, Liu B, Liu G, et al. The gut microbiota modulates neuroinflammation in Alzheimer\u2019s disease: elucidating crucial factors and mechanistic underpinnings. CNS Neurosci Ther. 2024;30(10):e70091.","journal-title":"CNS Neurosci Ther"},{"issue":"1","key":"796_CR81","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1186\/s13195-020-00741-z","volume":"13","author":"L Whiley","year":"2021","unstructured":"Whiley L, Chappell KE, D\u2019Hondt E, Lewis MR, Jimenez B, Snowden SG, et al. Metabolic phenotyping reveals a reduction in the bioavailability of serotonin and kynurenine pathway metabolites in both the urine and serum of individuals living with Alzheimer\u2019s disease. Alzheimers Res Ther. 2021;13(1):20.","journal-title":"Alzheimers Res Ther"},{"issue":"3","key":"796_CR82","first-page":"286","volume":"45","author":"BS Fernandes","year":"2023","unstructured":"Fernandes BS, Inam ME, Enduru N, Quevedo J, Zhao Z. The kynurenine pathway in Alzheimer\u2019s disease: a meta-analysis of central and peripheral levels. Braz J Psychiatry. 2023;45(3):286\u201397.","journal-title":"Braz J Psychiatry"},{"issue":"5","key":"796_CR83","first-page":"854","volume":"44","author":"B Eiseman","year":"1958","unstructured":"Eiseman B, Silen W, Bascom GS, Kauvar AJ. Fecal enema as an adjunct in the treatment of pseudomembranous Enterocolitis. Surgery. 1958;44(5):854\u20139.","journal-title":"Surgery"},{"key":"796_CR84","doi-asserted-by":"publisher","first-page":"1281233","DOI":"10.3389\/fmicb.2023.1281233","volume":"14","author":"W Xiang","year":"2023","unstructured":"Xiang W, Xiang H, Wang J, Jiang Y, Pan C, Ji B, et al. Fecal microbiota transplantation: a novel strategy for treating Alzheimer\u2019s disease. Front Microbiol. 2023;14:1281233.","journal-title":"Front Microbiol"},{"issue":"1","key":"796_CR85","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1038\/s41398-019-0525-3","volume":"9","author":"J Sun","year":"2019","unstructured":"Sun J, Xu J, Ling Y, Wang F, Gong T, Yang C, et al. Fecal microbiota transplantation alleviated Alzheimer\u2019s disease-like pathogenesis in APP\/PS1 Transgenic mice. Transl Psychiatry. 2019;9(1):189.","journal-title":"Transl Psychiatry"},{"issue":"1","key":"796_CR86","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/s12993-024-00265-8","volume":"21","author":"X Li","year":"2025","unstructured":"Li X, Ding Q, Wan X, Wu Q, Ye S, Lou Y. Fecal microbiota transplantation attenuates Alzheimer\u2019s disease symptoms in APP\/PS1 Transgenic mice via Inhibition of the TLR4-MyD88-NF-kappaB signaling pathway-mediated inflammation. Behav Brain Funct. 2025;21(1):2.","journal-title":"Behav Brain Funct"},{"issue":"2","key":"796_CR87","doi-asserted-by":"publisher","first-page":"e70259","DOI":"10.1111\/cns.70259","volume":"31","author":"X Jiang","year":"2025","unstructured":"Jiang X, Zheng Y, Sun H, Dang Y, Yin M, Xiao M, et al. Fecal microbiota transplantation improves cognitive function of a mouse model of Alzheimer\u2019s disease. CNS Neurosci Ther. 2025;31(2):e70259.","journal-title":"CNS Neurosci Ther"},{"issue":"2","key":"796_CR88","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1136\/gutjnl-2018-317431","volume":"69","author":"MS Kim","year":"2020","unstructured":"Kim MS, Kim Y, Choi H, Kim W, Park S, Lee D, et al. Transfer of a healthy microbiota reduces amyloid and Tau pathology in an Alzheimer\u2019s disease animal model. Gut. 2020;69(2):283\u201394.","journal-title":"Gut"},{"issue":"6628","key":"796_CR89","doi-asserted-by":"publisher","first-page":"eadd1236","DOI":"10.1126\/science.add1236","volume":"379","author":"DO Seo","year":"2023","unstructured":"Seo DO, O\u2019Donnell D, Jain N, Ulrich JD, Herz J, Li Y, et al. ApoE isoform- and microbiota-dependent progression of neurodegeneration in a mouse model of tauopathy. Science. 2023;379(6628):eadd1236.","journal-title":"Science"},{"issue":"6","key":"796_CR90","doi-asserted-by":"publisher","first-page":"300060520925930","DOI":"10.1177\/0300060520925930","volume":"48","author":"S Hazan","year":"2020","unstructured":"Hazan S. Rapid improvement in Alzheimer\u2019s disease symptoms following fecal microbiota transplantation: a case report. J Int Med Res. 2020;48(6):300060520925930.","journal-title":"J Int Med Res"},{"issue":"10","key":"796_CR91","doi-asserted-by":"publisher","first-page":"1739","DOI":"10.1080\/03007995.2021.1957807","volume":"37","author":"SH Park","year":"2021","unstructured":"Park SH, Lee JH, Shin J, Kim JS, Cha B, Lee S, et al. Cognitive function improvement after fecal microbiota transplantation in Alzheimer\u2019s dementia patient: a case report. Curr Med Res Opin. 2021;37(10):1739\u201344.","journal-title":"Curr Med Res Opin"},{"key":"796_CR92","doi-asserted-by":"publisher","first-page":"1103189","DOI":"10.3389\/fcimb.2023.1103189","volume":"13","author":"X Chen","year":"2023","unstructured":"Chen X, Zhang W, Lin Z, Zheng C, Chen S, Zhou H, et al. Preliminary evidence for developing safe and efficient fecal microbiota transplantation as potential treatment for aged related cognitive impairments. Front Cell Infect Microbiol. 2023;13:1103189.","journal-title":"Front Cell Infect Microbiol"},{"key":"796_CR93","doi-asserted-by":"publisher","first-page":"175628642312181","DOI":"10.1177\/17562864231218181","volume":"17","author":"JS Kim","year":"2024","unstructured":"Kim JS, Park H, Lee JH, Shin J, Cha B, Kwon KS, et al. Effect of altered gene expression in lipid metabolism on cognitive improvement in patients with Alzheimer\u2019s dementia following fecal microbiota transplantation: a preliminary study. Ther Adv Neurol Disord. 2024;17:17562864231218181.","journal-title":"Ther Adv Neurol Disord"},{"issue":"8","key":"796_CR94","doi-asserted-by":"publisher","first-page":"e0161174","DOI":"10.1371\/journal.pone.0161174","volume":"11","author":"S Wang","year":"2016","unstructured":"Wang S, Xu M, Wang W, Cao X, Piao M, Khan S, et al. Systematic review: adverse events of fecal microbiota transplantation. PLoS ONE. 2016;11(8):e0161174.","journal-title":"PLoS ONE"},{"issue":"340","key":"796_CR95","doi-asserted-by":"publisher","first-page":"340ra72","DOI":"10.1126\/scitranslmed.aaf1059","volume":"8","author":"DK Kumar","year":"2016","unstructured":"Kumar DK, Choi SH, Washicosky KJ, Eimer WA, Tucker S, Ghofrani J, et al. Amyloid-beta peptide protects against microbial infection in mouse and worm models of Alzheimer\u2019s disease. Sci Transl Med. 2016;8(340):340ra72.","journal-title":"Sci Transl Med"},{"issue":"3","key":"796_CR96","doi-asserted-by":"publisher","first-page":"e9505","DOI":"10.1371\/journal.pone.0009505","volume":"5","author":"SJ Soscia","year":"2010","unstructured":"Soscia SJ, Kirby JE, Washicosky KJ, Tucker SM, Ingelsson M, Hyman B, et al. The Alzheimer\u2019s disease-associated amyloid beta-protein is an antimicrobial peptide. PLoS ONE. 2010;5(3):e9505.","journal-title":"PLoS ONE"},{"issue":"5556","key":"796_CR97","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1126\/science.1067484","volume":"295","author":"MR Chapman","year":"2002","unstructured":"Chapman MR, Robinson LS, Pinkner JS, Roth R, Heuser J, Hammar M, et al. Role of Escherichia coli curli operons in directing amyloid fiber formation. Science. 2002;295(5556):851\u20135.","journal-title":"Science"},{"key":"796_CR98","doi-asserted-by":"publisher","first-page":"101351","DOI":"10.1016\/j.mam.2025.101351","volume":"103","author":"DE Otzen","year":"2025","unstructured":"Otzen DE, Pena-Diaz S, Widmann J, Daugberg AOH, Zhang Z, Jiang Y, et al. Interactions between pathological and functional amyloid: A match made in Heaven or hell? Mol Aspects Med. 2025;103:101351.","journal-title":"Mol Aspects Med"},{"key":"796_CR99","doi-asserted-by":"publisher","first-page":"41802","DOI":"10.1038\/srep41802","volume":"7","author":"T Harach","year":"2017","unstructured":"Harach T, Marungruang N, Duthilleul N, Cheatham V, Mc Coy KD, Frisoni G, et al. Reduction of Abeta amyloid pathology in APPPS1 Transgenic mice in the absence of gut microbiota. Sci Rep. 2017;7:41802.","journal-title":"Sci Rep"},{"issue":"1","key":"796_CR100","doi-asserted-by":"publisher","first-page":"10411","DOI":"10.1038\/s41598-017-11047-w","volume":"7","author":"MR Minter","year":"2017","unstructured":"Minter MR, Hinterleitner R, Meisel M, Zhang C, Leone V, Zhang X, et al. Antibiotic-induced perturbations in microbial diversity during post-natal development alters amyloid pathology in an aged APP(SWE)\/PS1(DeltaE9) murine model of Alzheimer\u2019s disease. Sci Rep. 2017;7(1):10411.","journal-title":"Sci Rep"},{"key":"796_CR101","doi-asserted-by":"publisher","first-page":"30028","DOI":"10.1038\/srep30028","volume":"6","author":"MR Minter","year":"2016","unstructured":"Minter MR, Zhang C, Leone V, Ringus DL, Zhang X, Oyler-Castrillo P, et al. Antibiotic-induced perturbations in gut microbial diversity influences neuro-inflammation and amyloidosis in a murine model of Alzheimer\u2019s disease. Sci Rep. 2016;6:30028.","journal-title":"Sci Rep"},{"issue":"1","key":"796_CR102","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1186\/s40478-020-00988-5","volume":"8","author":"C Mezo","year":"2020","unstructured":"Mezo C, Dokalis N, Mossad O, Staszewski O, Neuber J, Yilmaz B, et al. Different effects of constitutive and induced microbiota modulation on microglia in a mouse model of Alzheimer\u2019s disease. Acta Neuropathol Commun. 2020;8(1):119.","journal-title":"Acta Neuropathol Commun"},{"key":"796_CR103","doi-asserted-by":"publisher","first-page":"110159","DOI":"10.1016\/j.neuropharm.2024.110159","volume":"261","author":"JJ Jiao","year":"2024","unstructured":"Jiao JJ, Hu Y, Cui YJ, Tuo CM, Wang YX, Li XY, et al. Anisomycin alleviates cognitive impairments and pathological features in 3xTg-AD mice. Neuropharmacology. 2024;261:110159.","journal-title":"Neuropharmacology"},{"issue":"1","key":"796_CR104","doi-asserted-by":"publisher","first-page":"2363014","DOI":"10.1080\/19490976.2024.2363014","volume":"16","author":"W Hao","year":"2024","unstructured":"Hao W, Luo Q, Tomic I, Quan W, Hartmann T, Menger MD, et al. Modulation of Alzheimer\u2019s disease brain pathology in mice by gut bacterial depletion: the role of IL-17a. Gut Microbes. 2024;16(1):2363014.","journal-title":"Gut Microbes"},{"issue":"1","key":"796_CR105","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1186\/s12974-023-03004-4","volume":"21","author":"EJ Koller","year":"2024","unstructured":"Koller EJ, Wood CA, Lai Z, Borgenheimer E, Hoffman KL, Jankowsky JL. Doxycycline for transgene control disrupts gut Microbiome diversity without compromising acute neuroinflammatory response. J Neuroinflammation. 2024;21(1):11.","journal-title":"J Neuroinflammation"},{"issue":"32","key":"796_CR106","doi-asserted-by":"publisher","first-page":"5169","DOI":"10.2174\/1381612819666140110115603","volume":"20","author":"CH Lin","year":"2014","unstructured":"Lin CH, Huang YJ, Lin CJ, Lane HY, Tsai GE. NMDA neurotransmission dysfunction in mild cognitive impairment and Alzheimer\u2019s disease. Curr Pharm Des. 2014;20(32):5169\u201379.","journal-title":"Curr Pharm Des"},{"issue":"3","key":"796_CR107","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1176\/ajp.156.3.467","volume":"156","author":"GE Tsai","year":"1999","unstructured":"Tsai GE, Falk WE, Gunther J, Coyle JT. Improved cognition in Alzheimer\u2019s disease with short-term D-cycloserine treatment. Am J Psychiatry. 1999;156(3):467\u20139.","journal-title":"Am J Psychiatry"},{"issue":"1","key":"796_CR108","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1038\/s41398-023-02725-7","volume":"14","author":"S Vestring","year":"2024","unstructured":"Vestring S, Dorner A, Scholliers J, Ehrenberger K, Kiss A, Arenz L, et al. D-Cycloserine enhances the bidirectional range of NMDAR-dependent hippocampal synaptic plasticity. Transl Psychiatry. 2024;14(1):18.","journal-title":"Transl Psychiatry"},{"issue":"2","key":"796_CR109","first-page":"CD003153","volume":"2002","author":"K Laake","year":"2002","unstructured":"Laake K, Oeksengaard AR. D-cycloserine for Alzheimer\u2019s disease. Cochrane Database Syst Rev. 2002;2002(2):CD003153.","journal-title":"Cochrane Database Syst Rev"},{"key":"796_CR110","doi-asserted-by":"crossref","unstructured":"Raich I, Lillo J, Rebassa JB, Capo T, Cordomi A, Reyes-Resina I et al. Dual Role of NMDAR Containing NR2A and NR2B Subunits in Alzheimer\u2019s Disease. Int J Mol Sci. 2024;25(9).","DOI":"10.3390\/ijms25094757"},{"issue":"6","key":"796_CR111","doi-asserted-by":"publisher","first-page":"938","DOI":"10.1212\/01.wnl.0000203644.68059.5f","volume":"66","author":"J Kountouras","year":"2006","unstructured":"Kountouras J, Tsolaki M, Gavalas E, Boziki M, Zavos C, Karatzoglou P, et al. Relationship between Helicobacter pylori infection and Alzheimer disease. Neurology. 2006;66(6):938\u201340.","journal-title":"Neurology"},{"issue":"5","key":"796_CR112","doi-asserted-by":"publisher","first-page":"758","DOI":"10.1007\/s00415-009-5011-z","volume":"256","author":"J Kountouras","year":"2009","unstructured":"Kountouras J, Boziki M, Gavalas E, Zavos C, Grigoriadis N, Deretzi G, et al. Eradication of Helicobacter pylori May be beneficial in the management of Alzheimer\u2019s disease. J Neurol. 2009;256(5):758\u201367.","journal-title":"J Neurol"},{"issue":"1","key":"796_CR113","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1007\/s004300050071","volume":"187","author":"BJ Balin","year":"1998","unstructured":"Balin BJ, Gerard HC, Arking EJ, Appelt DM, Branigan PJ, Abrams JT, et al. Identification and localization of chlamydia pneumoniae in the Alzheimer\u2019s brain. Med Microbiol Immunol. 1998;187(1):23\u201342.","journal-title":"Med Microbiol Immunol"},{"issue":"3","key":"796_CR114","doi-asserted-by":"publisher","first-page":"957","DOI":"10.3233\/JAD-140621","volume":"43","author":"P Maheshwari","year":"2015","unstructured":"Maheshwari P, Eslick GD. Bacterial infection and Alzheimer\u2019s disease: a meta-analysis. J Alzheimers Dis. 2015;43(3):957\u201366.","journal-title":"J Alzheimers Dis"},{"issue":"12","key":"796_CR115","doi-asserted-by":"publisher","first-page":"6839","DOI":"10.1074\/jbc.271.12.6839","volume":"271","author":"T Tomiyama","year":"1996","unstructured":"Tomiyama T, Shoji A, Kataoka K, Suwa Y, Asano S, Kaneko H, et al. Inhibition of amyloid beta protein aggregation and neurotoxicity by rifampicin. Its possible function as a hydroxyl radical scavenger. J Biol Chem. 1996;271(12):6839\u201344.","journal-title":"J Biol Chem"},{"issue":"3","key":"796_CR116","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1111\/j.1532-5415.2004.52109.x","volume":"52","author":"MB Loeb","year":"2004","unstructured":"Loeb MB, Molloy DW, Smieja M, Standish T, Goldsmith CH, Mahony J, et al. A randomized, controlled trial of Doxycycline and Rifampin for patients with Alzheimer\u2019s disease. J Am Geriatr Soc. 2004;52(3):381\u20137.","journal-title":"J Am Geriatr Soc"},{"issue":"5","key":"796_CR117","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1002\/gps.3846","volume":"28","author":"DW Molloy","year":"2013","unstructured":"Molloy DW, Standish TI, Zhou Q, Guyatt G, Group DS. A multicenter, blinded, randomized, factorial controlled trial of Doxycycline and Rifampin for treatment of Alzheimer\u2019s disease: the DARAD trial. Int J Geriatr Psychiatry. 2013;28(5):463\u201370.","journal-title":"Int J Geriatr Psychiatry"},{"issue":"2","key":"796_CR118","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1001\/jamaneurol.2019.3762","volume":"77","author":"R Howard","year":"2020","unstructured":"Howard R, Zubko O, Bradley R, Harper E, Pank L, O\u2019Brien J, et al. Minocycline at 2 different dosages vs placebo for patients with mild Alzheimer disease: A randomized clinical trial. JAMA Neurol. 2020;77(2):164\u201374.","journal-title":"JAMA Neurol"},{"issue":"4","key":"796_CR119","doi-asserted-by":"publisher","first-page":"1329","DOI":"10.3233\/JAD-221153","volume":"93","author":"E Rakusa","year":"2023","unstructured":"Rakusa E, Fink A, Tamguney G, Heneka MT, Doblhammer G. Sporadic use of antibiotics in older adults and the risk of dementia: A nested Case-Control study based on German health claims data. J Alzheimers Dis. 2023;93(4):1329\u201339.","journal-title":"J Alzheimers Dis"},{"key":"796_CR120","doi-asserted-by":"crossref","unstructured":"Naomi R, Embong H, Othman F, Ghazi HF, Maruthey N, Bahari H. Probiotics for Alzheimer\u2019s Disease: A Systematic Review. Nutrients. 2021;14(1).","DOI":"10.3390\/nu14010020"},{"issue":"1","key":"796_CR121","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1186\/s40795-025-01152-9","volume":"11","author":"R Hashemi","year":"2025","unstructured":"Hashemi R, Raouf M, Salih TS, Feyzpour M, Eskandarioun M, Nezamabadipour N, et al. Impact of probiotic supplementation on serum levels of brain-derived neurotrophic factor: GRADE-based dose-response meta-analysis. BMC Nutr. 2025;11(1):161.","journal-title":"BMC Nutr"},{"key":"796_CR122","doi-asserted-by":"crossref","unstructured":"Hsu YC, Huang YY, Tsai SY, Kuo YW, Lin JH, Ho HH et al. Efficacy of Probiotic Supplements on Brain-Derived Neurotrophic Factor, Inflammatory Biomarkers, Oxidative Stress and Cognitive Function in Patients with Alzheimer\u2019s Dementia: A 12-Week Randomized, Double-Blind Active-Controlled Study. Nutrients. 2023;16(1).","DOI":"10.3390\/nu16010016"},{"issue":"2","key":"796_CR123","doi-asserted-by":"publisher","first-page":"e1900636","DOI":"10.1002\/mnfr.201900636","volume":"64","author":"J Sun","year":"2020","unstructured":"Sun J, Xu J, Yang B, Chen K, Kong Y, Fang N, et al. Effect of clostridium Butyricum against Microglia-Mediated neuroinflammation in Alzheimer\u2019s disease via regulating gut microbiota and metabolites butyrate. Mol Nutr Food Res. 2020;64(2):e1900636.","journal-title":"Mol Nutr Food Res"},{"issue":"4","key":"796_CR124","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1007\/s12017-011-8154-x","volume":"13","author":"BS Diniz","year":"2011","unstructured":"Diniz BS, Teixeira AL. Brain-derived neurotrophic factor and Alzheimer\u2019s disease: physiopathology and beyond. Neuromolecular Med. 2011;13(4):217\u201322.","journal-title":"Neuromolecular Med"},{"issue":"3","key":"796_CR125","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1080\/09637486.2017.1365824","volume":"69","author":"K Ohsawa","year":"2018","unstructured":"Ohsawa K, Nakamura F, Uchida N, Mizuno S, Yokogoshi H. Lactobacillus helveticus-fermented milk containing lactononadecapeptide (NIPPLTQTPVVVPPFLQPE) improves cognitive function in healthy middle-aged adults: a randomised, double-blind, placebo-controlled trial. Int J Food Sci Nutr. 2018;69(3):369\u201376.","journal-title":"Int J Food Sci Nutr"},{"issue":"1","key":"796_CR126","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1093\/gerona\/glaa090","volume":"76","author":"CS Kim","year":"2021","unstructured":"Kim CS, Cha L, Sim M, Jung S, Chun WY, Baik HW, et al. Probiotic supplementation improves cognitive function and mood with changes in gut microbiota in Community-Dwelling older adults: A Randomized, Double-Blind, Placebo-Controlled, multicenter trial. J Gerontol Biol Sci Med Sci. 2021;76(1):32\u201340.","journal-title":"J Gerontol Biol Sci Med Sci"},{"issue":"8","key":"796_CR127","first-page":"KC01","volume":"11","author":"M Nimgampalle","year":"2017","unstructured":"Nimgampalle M, Kuna Y. Anti-Alzheimer properties of Probiotic, Lactobacillus plantarum MTCC 1325 in Alzheimer\u2019s disease induced albino rats. J Clin Diagn Res. 2017;11(8):KC01\u20135.","journal-title":"J Clin Diagn Res"},{"key":"796_CR128","doi-asserted-by":"publisher","first-page":"112183","DOI":"10.1016\/j.bbr.2019.112183","volume":"376","author":"Z Rezaei Asl","year":"2019","unstructured":"Rezaei Asl Z, Sepehri G, Salami M. Probiotic treatment improves the impaired Spatial cognitive performance and restores synaptic plasticity in an animal model of Alzheimer\u2019s disease. Behav Brain Res. 2019;376:112183.","journal-title":"Behav Brain Res"},{"issue":"1","key":"796_CR129","doi-asserted-by":"publisher","first-page":"2426","DOI":"10.1038\/s41598-017-02587-2","volume":"7","author":"L Bonfili","year":"2017","unstructured":"Bonfili L, Cecarini V, Berardi S, Scarpona S, Suchodolski JS, Nasuti C, et al. Microbiota modulation counteracts Alzheimer\u2019s disease progression influencing neuronal proteolysis and gut hormones plasma levels. Sci Rep. 2017;7(1):2426.","journal-title":"Sci Rep"},{"issue":"1","key":"796_CR130","doi-asserted-by":"publisher","first-page":"13510","DOI":"10.1038\/s41598-017-13368-2","volume":"7","author":"Y Kobayashi","year":"2017","unstructured":"Kobayashi Y, Sugahara H, Shimada K, Mitsuyama E, Kuhara T, Yasuoka A, et al. Therapeutic potential of bifidobacterium Breve strain A1 for preventing cognitive impairment in Alzheimer\u2019s disease. Sci Rep. 2017;7(1):13510.","journal-title":"Sci Rep"},{"issue":"1","key":"796_CR131","doi-asserted-by":"publisher","first-page":"217","DOI":"10.3233\/JAD-2012-120478","volume":"32","author":"AB Wolf","year":"2012","unstructured":"Wolf AB, Braden BB, Bimonte-Nelson H, Kusne Y, Young N, Engler-Chiurazzi E, et al. Broad-based nutritional supplementation in 3xTg mice corrects mitochondrial function and indicates sex-specificity in response to Alzheimer\u2019s disease intervention. J Alzheimers Dis. 2012;32(1):217\u201332.","journal-title":"J Alzheimers Dis"},{"issue":"1","key":"796_CR132","doi-asserted-by":"publisher","first-page":"70","DOI":"10.14283\/jpad.2018.32","volume":"6","author":"Y Kobayashi","year":"2019","unstructured":"Kobayashi Y, Kinoshita T, Matsumoto A, Yoshino K, Saito I, Xiao JZ. Bifidobacterium Breve A1 supplementation improved cognitive decline in older adults with mild cognitive impairment: an Open-Label, Single-Arm study. J Prev Alzheimers Dis. 2019;6(1):70\u20135.","journal-title":"J Prev Alzheimers Dis"},{"issue":"1","key":"796_CR133","doi-asserted-by":"publisher","first-page":"139","DOI":"10.3233\/JAD-200488","volume":"77","author":"J Xiao","year":"2020","unstructured":"Xiao J, Katsumata N, Bernier F, Ohno K, Yamauchi Y, Odamaki T, et al. Probiotic bifidobacterium Breve in improving cognitive functions of older adults with suspected mild cognitive impairment: A Randomized, Double-Blind, Placebo-Controlled trial. J Alzheimers Dis. 2020;77(1):139\u201347.","journal-title":"J Alzheimers Dis"},{"issue":"2","key":"796_CR134","doi-asserted-by":"publisher","first-page":"774","DOI":"10.1177\/13872877251345157","volume":"106","author":"L Loffredo","year":"2025","unstructured":"Loffredo L, Alfano AR, Ettorre E, Desideri G, Carnevale R, Forte M, et al. Effect of the probiotic Escherichia coli Nissle 1917 on serum levels of NADPH oxidase-2 and lipopolysaccharide in patients with Alzheimer\u2019s disease. J Alzheimers Dis. 2025;106(2):774\u201382.","journal-title":"J Alzheimers Dis"},{"key":"796_CR135","doi-asserted-by":"publisher","first-page":"662","DOI":"10.3389\/fneur.2018.00662","volume":"9","author":"A Agahi","year":"2018","unstructured":"Agahi A, Hamidi GA, Daneshvar R, Hamdieh M, Soheili M, Alinaghipour A, et al. Does severity of Alzheimer\u2019s disease contribute to its responsiveness to modifying gut microbiota? A double blind clinical trial. Front Neurol. 2018;9:662.","journal-title":"Front Neurol"},{"issue":"6","key":"796_CR136","doi-asserted-by":"publisher","first-page":"2569","DOI":"10.1016\/j.clnu.2018.11.034","volume":"38","author":"OR Tamtaji","year":"2019","unstructured":"Tamtaji OR, Heidari-Soureshjani R, Mirhosseini N, Kouchaki E, Bahmani F, Aghadavod E, et al. Probiotic and selenium co-supplementation, and the effects on clinical, metabolic and genetic status in Alzheimer\u2019s disease: A randomized, double-blind, controlled trial. Clin Nutr. 2019;38(6):2569\u201375.","journal-title":"Clin Nutr"},{"key":"796_CR137","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1016\/j.exger.2018.12.005","volume":"115","author":"D Abraham","year":"2019","unstructured":"Abraham D, Feher J, Scuderi GL, Szabo D, Dobolyi A, Cservenak M, et al. Exercise and probiotics attenuate the development of Alzheimer\u2019s disease in Transgenic mice: role of Microbiome. Exp Gerontol. 2019;115:122\u201331.","journal-title":"Exp Gerontol"},{"issue":"6","key":"796_CR138","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1007\/s10522-020-09895-7","volume":"21","author":"T Teglas","year":"2020","unstructured":"Teglas T, Abraham D, Jokai M, Kondo S, Mohammadi R, Feher J, et al. Exercise combined with a probiotics treatment alters the microbiome, but moderately affects signalling pathways in the liver of male APP\/PS1 Transgenic mice. Biogerontology. 2020;21(6):807\u201315.","journal-title":"Biogerontology"},{"issue":"6086","key":"796_CR139","doi-asserted-by":"publisher","first-page":"1262","DOI":"10.1126\/science.1223813","volume":"336","author":"JK Nicholson","year":"2012","unstructured":"Nicholson JK, Holmes E, Kinross J, Burcelin R, Gibson G, Jia W, et al. Host-gut microbiota metabolic interactions. Science. 2012;336(6086):1262\u20137.","journal-title":"Science"},{"key":"796_CR140","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.aca.2019.04.021","volume":"1070","author":"J Zheng","year":"2019","unstructured":"Zheng J, Zheng SJ, Cai WJ, Yu L, Yuan BF, Feng YQ. Stable isotope labeling combined with liquid chromatography-tandem mass spectrometry for comprehensive analysis of short-chain fatty acids. Anal Chim Acta. 2019;1070:51\u20139.","journal-title":"Anal Chim Acta"},{"issue":"6","key":"796_CR141","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1046\/j.1365-2036.1998.00337.x","volume":"12","author":"SI Cook","year":"1998","unstructured":"Cook SI, Sellin JH. Review article: short chain fatty acids in health and disease. Aliment Pharmacol Ther. 1998;12(6):499\u2013507.","journal-title":"Aliment Pharmacol Ther"},{"issue":"9","key":"796_CR142","doi-asserted-by":"publisher","first-page":"2325","DOI":"10.1194\/jlr.R036012","volume":"54","author":"G den Besten","year":"2013","unstructured":"den Besten G, van Eunen K, Groen AK, Venema K, Reijngoud DJ, Bakker BM. The role of short-chain fatty acids in the interplay between diet, gut microbiota, and host energy metabolism. J Lipid Res. 2013;54(9):2325\u201340.","journal-title":"J Lipid Res"},{"issue":"1","key":"796_CR143","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1186\/s40168-018-0439-y","volume":"6","author":"L Hoyles","year":"2018","unstructured":"Hoyles L, Snelling T, Umlai UK, Nicholson JK, Carding SR, Glen RC, et al. Microbiome-host systems interactions: protective effects of propionate upon the blood-brain barrier. Microbiome. 2018;6(1):55.","journal-title":"Microbiome"},{"key":"796_CR144","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1016\/j.brainresbull.2020.08.017","volume":"164","author":"J Wen","year":"2020","unstructured":"Wen J, Ding Y, Wang L, Xiao Y. Gut Microbiome improves postoperative cognitive function by decreasing permeability of the blood-brain barrier in aged mice. Brain Res Bull. 2020;164:249\u201356.","journal-title":"Brain Res Bull"},{"issue":"1","key":"796_CR145","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1080\/14737175.2018.1400909","volume":"18","author":"L Ho","year":"2018","unstructured":"Ho L, Ono K, Tsuji M, Mazzola P, Singh R, Pasinetti GM. Protective roles of intestinal microbiota derived short chain fatty acids in Alzheimer\u2019s disease-type beta-amyloid neuropathological mechanisms. Expert Rev Neurother. 2018;18(1):83\u201390.","journal-title":"Expert Rev Neurother"},{"key":"796_CR146","doi-asserted-by":"publisher","first-page":"7605160","DOI":"10.1155\/2020\/7605160","volume":"2020","author":"J Sun","year":"2020","unstructured":"Sun J, Yuan B, Wu Y, Gong Y, Guo W, Fu S, et al. Sodium butyrate protects N2a cells against Abeta toxicity in vitro. Mediators Inflamm. 2020;2020:7605160.","journal-title":"Mediators Inflamm"},{"issue":"6","key":"796_CR147","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1038\/s41419-020-2663-1","volume":"11","author":"SY Kim","year":"2020","unstructured":"Kim SY, Chae CW, Lee HJ, Jung YH, Choi GE, Kim JS, et al. Sodium butyrate inhibits high cholesterol-induced neuronal amyloidogenesis by modulating NRF2 stabilization-mediated ROS levels: involvement of NOX2 and SOD1. Cell Death Dis. 2020;11(6):469.","journal-title":"Cell Death Dis"},{"key":"796_CR148","doi-asserted-by":"publisher","first-page":"109452","DOI":"10.1016\/j.cbi.2021.109452","volume":"341","author":"Y Jiang","year":"2021","unstructured":"Jiang Y, Li K, Li X, Xu L, Yang Z. Sodium butyrate ameliorates the impairment of synaptic plasticity by inhibiting the neuroinflammation in 5XFAD mice. Chem Biol Interact. 2021;341:109452.","journal-title":"Chem Biol Interact"},{"issue":"1","key":"796_CR149","doi-asserted-by":"publisher","first-page":"91","DOI":"10.3233\/JAD-190120","volume":"74","author":"W Fernando","year":"2020","unstructured":"Fernando W, Martins IJ, Morici M, Bharadwaj P, Rainey-Smith SR, Lim WLF, et al. Sodium butyrate reduces brain Amyloid-beta levels and improves cognitive memory performance in an Alzheimer\u2019s disease Transgenic mouse model at an early disease stage. J Alzheimers Dis. 2020;74(1):91\u20139.","journal-title":"J Alzheimers Dis"},{"key":"796_CR150","doi-asserted-by":"crossref","unstructured":"Colombo AV, Sadler RK, Llovera G, Singh V, Roth S, Heindl S et al. Microbiota-derived short chain fatty acids modulate microglia and promote Abeta plaque deposition. Elife. 2021;10.","DOI":"10.7554\/eLife.59826"},{"issue":"11","key":"796_CR151","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1016\/j.tins.2009.06.002","volume":"32","author":"DM Chuang","year":"2009","unstructured":"Chuang DM, Leng Y, Marinova Z, Kim HJ, Chiu CT. Multiple roles of HDAC Inhibition in neurodegenerative conditions. Trends Neurosci. 2009;32(11):591\u2013601.","journal-title":"Trends Neurosci"},{"issue":"1","key":"796_CR152","doi-asserted-by":"publisher","first-page":"187","DOI":"10.3233\/JAD-2011-110080","volume":"26","author":"N Govindarajan","year":"2011","unstructured":"Govindarajan N, Agis-Balboa RC, Walter J, Sananbenesi F, Fischer A. Sodium butyrate improves memory function in an Alzheimer\u2019s disease mouse model when administered at an advanced stage of disease progression. J Alzheimers Dis. 2011;26(1):187\u201397.","journal-title":"J Alzheimers Dis"},{"issue":"7","key":"796_CR153","doi-asserted-by":"publisher","first-page":"1721","DOI":"10.1038\/npp.2008.229","volume":"34","author":"A Ricobaraza","year":"2009","unstructured":"Ricobaraza A, Cuadrado-Tejedor M, Perez-Mediavilla A, Frechilla D, Del Rio J, Garcia-Osta A. Phenylbutyrate ameliorates cognitive deficit and reduces Tau pathology in an Alzheimer\u2019s disease mouse model. Neuropsychopharmacology. 2009;34(7):1721\u201332.","journal-title":"Neuropsychopharmacology"},{"issue":"3","key":"796_CR154","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1016\/j.immuni.2018.02.016","volume":"48","author":"M Datta","year":"2018","unstructured":"Datta M, Staszewski O, Raschi E, Frosch M, Hagemeyer N, Tay TL, et al. Histone deacetylases 1 and 2 regulate microglia function during Development, Homeostasis, and neurodegeneration in a Context-Dependent manner. Immunity. 2018;48(3):514\u201329. e6.","journal-title":"Immunity"},{"issue":"1","key":"796_CR155","doi-asserted-by":"publisher","first-page":"734","DOI":"10.1007\/s12035-014-8914-3","volume":"52","author":"T Barichello","year":"2015","unstructured":"Barichello T, Generoso JS, Simoes LR, Faller CJ, Ceretta RA, Petronilho F, et al. Sodium butyrate prevents memory impairment by Re-establishing BDNF and GDNF expression in experimental Pneumococcal meningitis. Mol Neurobiol. 2015;52(1):734\u201340.","journal-title":"Mol Neurobiol"},{"issue":"1","key":"796_CR156","doi-asserted-by":"publisher","first-page":"2819","DOI":"10.1038\/s41598-022-27086-x","volume":"13","author":"ME Caetano-Silva","year":"2023","unstructured":"Caetano-Silva ME, Rund L, Hutchinson NT, Woods JA, Steelman AJ, Johnson RW. Inhibition of inflammatory microglia by dietary fiber and short-chain fatty acids. Sci Rep. 2023;13(1):2819.","journal-title":"Sci Rep"},{"issue":"1","key":"796_CR157","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1111\/1462-2920.13589","volume":"19","author":"P Louis","year":"2017","unstructured":"Louis P, Flint HJ. Formation of propionate and butyrate by the human colonic microbiota. Environ Microbiol. 2017;19(1):29\u201341.","journal-title":"Environ Microbiol"},{"issue":"5","key":"796_CR158","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1002\/jnr.10063","volume":"66","author":"GA Dienel","year":"2001","unstructured":"Dienel GA, Liu K, Cruz NF. Local uptake of (14)C-labeled acetate and butyrate in rat brain in vivo during spreading cortical depression. J Neurosci Res. 2001;66(5):812\u201320.","journal-title":"J Neurosci Res"},{"issue":"1","key":"796_CR159","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1186\/s40168-024-02001-w","volume":"13","author":"Z Wang","year":"2025","unstructured":"Wang Z, Wang C, Yuan B, Liu L, Zhang H, Zhu M, et al. Akkermansia muciniphila and its metabolite propionic acid maintains neuronal mitochondrial division and autophagy homeostasis during Alzheimer\u2019s disease pathologic process via GPR41 and GPR43. Microbiome. 2025;13(1):16.","journal-title":"Microbiome"},{"issue":"3","key":"796_CR160","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1016\/S1474-4422(18)30028-0","volume":"17","author":"BA Gordon","year":"2018","unstructured":"Gordon BA, Blazey TM, Su Y, Hari-Raj A, Dincer A, Flores S, et al. Spatial patterns of neuroimaging biomarker change in individuals from families with autosomal dominant Alzheimer\u2019s disease: a longitudinal study. Lancet Neurol. 2018;17(3):241\u201350.","journal-title":"Lancet Neurol"},{"key":"796_CR161","doi-asserted-by":"publisher","first-page":"22","DOI":"10.3390\/ijms21228767","volume":"21","author":"NJ Jensen","year":"2020","unstructured":"Jensen NJ, Wodschow HZ, Nilsson M, Rungby J. Effects of ketone bodies on brain metabolism and function in neurodegenerative diseases. Int J Mol Sci. 2020;21:22.","journal-title":"Int J Mol Sci"},{"issue":"3","key":"796_CR162","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1016\/j.plefa.2003.11.001","volume":"70","author":"T Fukao","year":"2004","unstructured":"Fukao T, Lopaschuk GD, Mitchell GA. Pathways and control of ketone body metabolism: on the fringe of lipid biochemistry. Prostaglandins Leukot Essent Fat Acids. 2004;70(3):243\u201351.","journal-title":"Prostaglandins Leukot Essent Fat Acids"},{"issue":"4","key":"796_CR163","doi-asserted-by":"publisher","first-page":"1343","DOI":"10.3233\/JAD-141074","volume":"43","author":"CA Castellano","year":"2015","unstructured":"Castellano CA, Nugent S, Paquet N, Tremblay S, Bocti C, Lacombe G, et al. Lower brain 18F-fluorodeoxyglucose uptake but normal 11\u00a0C-acetoacetate metabolism in mild Alzheimer\u2019s disease dementia. J Alzheimers Dis. 2015;43(4):1343\u201353.","journal-title":"J Alzheimers Dis"},{"key":"796_CR164","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1186\/1743-7075-2-28","volume":"2","author":"I Van der Auwera","year":"2005","unstructured":"Van der Auwera I, Wera S, Van Leuven F, Henderson ST. A ketogenic diet reduces amyloid beta 40 and 42 in a mouse model of Alzheimer\u2019s disease. Nutr Metab (Lond). 2005;2:28.","journal-title":"Nutr Metab (Lond)"},{"key":"796_CR165","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.neurobiolaging.2015.11.018","volume":"39","author":"JX Yin","year":"2016","unstructured":"Yin JX, Maalouf M, Han P, Zhao M, Gao M, Dharshaun T, et al. Ketones block amyloid entry and improve cognition in an Alzheimer\u2019s model. Neurobiol Aging. 2016;39:25\u201337.","journal-title":"Neurobiol Aging"},{"key":"796_CR166","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1016\/j.brainres.2008.06.005","volume":"1226","author":"CM Studzinski","year":"2008","unstructured":"Studzinski CM, MacKay WA, Beckett TL, Henderson ST, Murphy MP, Sullivan PG, et al. Induction of ketosis May improve mitochondrial function and decrease steady-state amyloid-beta precursor protein (APP) levels in the aged dog. Brain Res. 2008;1226:209\u201317.","journal-title":"Brain Res"},{"issue":"2","key":"796_CR167","doi-asserted-by":"publisher","first-page":"e42519","DOI":"10.1016\/j.neurobiolaging.2010.10.006","volume":"33","author":"R Krikorian","year":"2012","unstructured":"Krikorian R, Shidler MD, Dangelo K, Couch SC, Benoit SC, Clegg DJ. Dietary ketosis enhances memory in mild cognitive impairment. Neurobiol Aging. 2012;33(2):e42519\u201327.","journal-title":"Neurobiol Aging"},{"key":"796_CR168","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1186\/1743-7075-6-31","volume":"6","author":"ST Henderson","year":"2009","unstructured":"Henderson ST, Vogel JL, Barr LJ, Garvin F, Jones JJ, Costantini LC. Study of the ketogenic agent AC-1202 in mild to moderate Alzheimer\u2019s disease: a randomized, double-blind, placebo-controlled, multicenter trial. Nutr Metab (Lond). 2009;6:31.","journal-title":"Nutr Metab (Lond)"},{"issue":"7","key":"796_CR169","doi-asserted-by":"publisher","first-page":"2092","DOI":"10.1016\/j.clnu.2019.10.017","volume":"39","author":"Q Xu","year":"2020","unstructured":"Xu Q, Zhang Y, Zhang X, Liu L, Zhou B, Mo R, et al. Medium-chain triglycerides improved cognition and lipid metabolomics in mild to moderate Alzheimer\u2019s disease patients with APOE4(-\/-): A double-blind, randomized, placebo-controlled crossover trial. Clin Nutr. 2020;39(7):2092\u2013105.","journal-title":"Clin Nutr"},{"issue":"26","key":"796_CR170","doi-asserted-by":"publisher","first-page":"2599","DOI":"10.1056\/NEJMoa025039","volume":"348","author":"A Trichopoulou","year":"2003","unstructured":"Trichopoulou A, Costacou T, Bamia C, Trichopoulos D. Adherence to a mediterranean diet and survival in a Greek population. N Engl J Med. 2003;348(26):2599\u2013608.","journal-title":"N Engl J Med"},{"issue":"6","key":"796_CR171","doi-asserted-by":"publisher","first-page":"1548","DOI":"10.1111\/jgs.17072","volume":"69","author":"S Charisis","year":"2021","unstructured":"Charisis S, Ntanasi E, Yannakoulia M, Anastasiou CA, Kosmidis MH, Dardiotis E, et al. Mediterranean diet and risk for dementia and cognitive decline in a mediterranean population. J Am Geriatr Soc. 2021;69(6):1548\u201359.","journal-title":"J Am Geriatr Soc"},{"issue":"6","key":"796_CR172","doi-asserted-by":"publisher","first-page":"1300","DOI":"10.1080\/1028415X.2020.1853416","volume":"25","author":"R Zupo","year":"2022","unstructured":"Zupo R, Griseta C, Battista P, Donghia R, Guerra V, Castellana F, et al. Role of plant-based diet in late-life cognitive decline: results from the Salus in Apulia study. Nutr Neurosci. 2022;25(6):1300\u20139.","journal-title":"Nutr Neurosci"},{"issue":"11","key":"796_CR173","doi-asserted-by":"publisher","first-page":"e023664","DOI":"10.1136\/bmjopen-2018-023664","volume":"8","author":"MJ Walters","year":"2018","unstructured":"Walters MJ, Sterling J, Quinn C, Ganzer C, Osorio RS, Andrews RD, et al. Associations of lifestyle and vascular risk factors with Alzheimer\u2019s brain biomarker changes during middle age: a 3-year longitudinal study in the broader new York City area. BMJ Open. 2018;8(11):e023664.","journal-title":"BMJ Open"},{"issue":"1","key":"796_CR174","doi-asserted-by":"publisher","first-page":"281","DOI":"10.3233\/JAD-171121","volume":"64","author":"M Vassilaki","year":"2018","unstructured":"Vassilaki M, Aakre JA, Syrjanen JA, Mielke MM, Geda YE, Kremers WK, et al. Mediterranean Diet, its Components, and amyloid imaging biomarkers. J Alzheimers Dis. 2018;64(1):281\u201390.","journal-title":"J Alzheimers Dis"},{"issue":"20","key":"796_CR175","doi-asserted-by":"publisher","first-page":"1744","DOI":"10.1212\/WNL.0000000000002121","volume":"85","author":"Y Gu","year":"2015","unstructured":"Gu Y, Brickman AM, Stern Y, Habeck CG, Razlighi QR, Luchsinger JA, et al. Mediterranean diet and brain structure in a multiethnic elderly cohort. Neurology. 2015;85(20):1744\u201351.","journal-title":"Neurology"},{"issue":"3","key":"796_CR176","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1002\/alz.12421","volume":"18","author":"S Hoscheidt","year":"2022","unstructured":"Hoscheidt S, Sanderlin AH, Baker LD, Jung Y, Lockhart S, Kellar D, et al. Mediterranean and Western diet effects on Alzheimer\u2019s disease biomarkers, cerebral perfusion, and cognition in mid-life: A randomized trial. Alzheimers Dement. 2022;18(3):457\u201368.","journal-title":"Alzheimers Dement"},{"key":"796_CR177","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/j.neurobiolaging.2019.09.015","volume":"86","author":"BJ Neth","year":"2020","unstructured":"Neth BJ, Mintz A, Whitlow C, Jung Y, Solingapuram Sai K, Register TC, et al. Modified ketogenic diet is associated with improved cerebrospinal fluid biomarker profile, cerebral perfusion, and cerebral ketone body uptake in older adults at risk for Alzheimer\u2019s disease: a pilot study. Neurobiol Aging. 2020;86:54\u201363.","journal-title":"Neurobiol Aging"},{"issue":"7","key":"796_CR178","doi-asserted-by":"publisher","first-page":"940","DOI":"10.1001\/archneur.60.7.940","volume":"60","author":"MC Morris","year":"2003","unstructured":"Morris MC, Evans DA, Bienias JL, Tangney CC, Bennett DA, Wilson RS, et al. Consumption of fish and n-3 fatty acids and risk of incident Alzheimer disease. Arch Neurol. 2003;60(7):940\u20136.","journal-title":"Arch Neurol"},{"issue":"7","key":"796_CR179","doi-asserted-by":"publisher","first-page":"1094","DOI":"10.1001\/jamainternmed.2015.1668","volume":"175","author":"C Valls-Pedret","year":"2015","unstructured":"Valls-Pedret C, Sala-Vila A, Serra-Mir M, Corella D, de la Torre R, Martinez-Gonzalez MA, et al. Mediterranean diet and Age-Related cognitive decline: A randomized clinical trial. JAMA Intern Med. 2015;175(7):1094\u2013103.","journal-title":"JAMA Intern Med"},{"issue":"4","key":"796_CR180","doi-asserted-by":"publisher","first-page":"2184","DOI":"10.1039\/C7FO01815K","volume":"9","author":"M Wen","year":"2018","unstructured":"Wen M, Ding L, Zhang L, Cong P, Zhang T, Xu J, et al. A comparative study of eicosapentaenoic acid enriched phosphatidylcholine and Ethyl ester in improving cognitive deficiency in Alzheimer\u2019s disease model rats. Food Funct. 2018;9(4):2184\u201392.","journal-title":"Food Funct"},{"key":"796_CR181","doi-asserted-by":"crossref","unstructured":"Zagoskina NV, Zubova MY, Nechaeva TL, Kazantseva VV, Goncharuk EA, Katanskaya VM et al. Polyphenols in plants: Structure, Biosynthesis, abiotic stress Regulation, and practical applications (Review). Int J Mol Sci. 2023;24(18).","DOI":"10.3390\/ijms241813874"},{"key":"796_CR182","doi-asserted-by":"publisher","first-page":"1144677","DOI":"10.3389\/fnut.2023.1144677","volume":"10","author":"TKO Rosales","year":"2023","unstructured":"Rosales TKO, Fabi JP. Valorization of polyphenolic compounds from food industry by-products for application in polysaccharide-based nanoparticles. Front Nutr. 2023;10:1144677.","journal-title":"Front Nutr"},{"issue":"6","key":"796_CR183","doi-asserted-by":"publisher","first-page":"229","DOI":"10.6026\/97320630006229","volume":"6","author":"D Paris","year":"2011","unstructured":"Paris D, Mathura V, Ait-Ghezala G, Beaulieu-Abdelahad D, Patel N, Bachmeier C, et al. Flavonoids lower Alzheimer\u2019s Abeta production via an NFkappaB dependent mechanism. Bioinformation. 2011;6(6):229\u201336.","journal-title":"Bioinformation"},{"issue":"2","key":"796_CR184","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1111\/jnc.13270","volume":"135","author":"EY Hayden","year":"2015","unstructured":"Hayden EY, Yamin G, Beroukhim S, Chen B, Kibalchenko M, Jiang L, et al. Inhibiting amyloid beta-protein assembly: Size-activity relationships among grape seed-derived polyphenols. J Neurochem. 2015;135(2):416\u201330.","journal-title":"J Neurochem"},{"issue":"2","key":"796_CR185","doi-asserted-by":"publisher","first-page":"433","DOI":"10.3233\/JAD-2009-0969","volume":"16","author":"L Ho","year":"2009","unstructured":"Ho L, Yemul S, Wang J, Pasinetti GM. Grape seed polyphenolic extract as a potential novel therapeutic agent in tauopathies. J Alzheimers Dis. 2009;16(2):433\u20139.","journal-title":"J Alzheimers Dis"},{"issue":"17","key":"796_CR186","doi-asserted-by":"publisher","first-page":"7710","DOI":"10.1073\/pnas.0910723107","volume":"107","author":"J Bieschke","year":"2010","unstructured":"Bieschke J, Russ J, Friedrich RP, Ehrnhoefer DE, Wobst H, Neugebauer K, et al. EGCG remodels mature alpha-synuclein and amyloid-beta fibrils and reduces cellular toxicity. Proc Natl Acad Sci U S A. 2010;107(17):7710\u20135.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"3","key":"796_CR187","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1016\/j.nbd.2006.08.006","volume":"24","author":"RE Hartman","year":"2006","unstructured":"Hartman RE, Shah A, Fagan AM, Schwetye KE, Parsadanian M, Schulman RN, et al. Pomegranate juice decreases amyloid load and improves behavior in a mouse model of Alzheimer\u2019s disease. Neurobiol Dis. 2006;24(3):506\u201315.","journal-title":"Neurobiol Dis"},{"key":"796_CR188","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/S1054-3589(08)60983-7","volume":"38","author":"LG Korkina","year":"1997","unstructured":"Korkina LG, Afanas\u2019ev IB. Antioxidant and chelating properties of flavonoids. Adv Pharmacol. 1997;38:151\u201363.","journal-title":"Adv Pharmacol"},{"issue":"12","key":"796_CR189","first-page":"1606","volume":"25","author":"YG Zhu","year":"2004","unstructured":"Zhu YG, Chen XC, Chen ZZ, Zeng YQ, Shi GB, Su YH, et al. Curcumin protects mitochondria from oxidative damage and attenuates apoptosis in cortical neurons. Acta Pharmacol Sin. 2004;25(12):1606\u201312.","journal-title":"Acta Pharmacol Sin"},{"issue":"4","key":"796_CR190","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.3892\/etm.2016.3077","volume":"11","author":"WM Chen","year":"2016","unstructured":"Chen WM, Shaw LH, Chang PJ, Tung SY, Chang TS, Shen CH, et al. Hepatoprotective effect of Resveratrol against ethanol-induced oxidative stress through induction of superoxide dismutase in vivo and in vitro. Exp Ther Med. 2016;11(4):1231\u20138.","journal-title":"Exp Ther Med"},{"issue":"4","key":"796_CR191","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1093\/jn\/133.4.985","volume":"133","author":"YJ Choi","year":"2003","unstructured":"Choi YJ, Kang JS, Park JH, Lee YJ, Choi JS, Kang YH. Polyphenolic flavonoids differ in their antiapoptotic efficacy in hydrogen peroxide-treated human vascular endothelial cells. J Nutr. 2003;133(4):985\u201391.","journal-title":"J Nutr"},{"issue":"5","key":"796_CR192","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1080\/10715760290025951","volume":"36","author":"CG Heijnen","year":"2002","unstructured":"Heijnen CG, Haenen GR, Oostveen RM, Stalpers EM, Bast A. Protection of flavonoids against lipid peroxidation: the structure activity relationship revisited. Free Radic Res. 2002;36(5):575\u201381.","journal-title":"Free Radic Res"},{"key":"796_CR193","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.bbr.2015.04.028","volume":"289","author":"A Nakajima","year":"2015","unstructured":"Nakajima A, Aoyama Y, Shin EJ, Nam Y, Kim HC, Nagai T, et al. Nobiletin, a citrus flavonoid, improves cognitive impairment and reduces soluble Abeta levels in a triple Transgenic mouse model of Alzheimer\u2019s disease (3XTg-AD). Behav Brain Res. 2015;289:69\u201377.","journal-title":"Behav Brain Res"},{"issue":"3","key":"796_CR194","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1111\/j.1471-4159.2011.07594.x","volume":"120","author":"H Capiralla","year":"2012","unstructured":"Capiralla H, Vingtdeux V, Zhao H, Sankowski R, Al-Abed Y, Davies P, et al. Resveratrol mitigates lipopolysaccharide- and Abeta-mediated microglial inflammation by inhibiting the TLR4\/NF-kappaB\/STAT signaling cascade. J Neurochem. 2012;120(3):461\u201372.","journal-title":"J Neurochem"},{"issue":"4","key":"796_CR195","doi-asserted-by":"publisher","first-page":"2125","DOI":"10.1007\/s10787-024-01492-1","volume":"32","author":"N Esmaealzadeh","year":"2024","unstructured":"Esmaealzadeh N, Miri MS, Mavaddat H, Peyrovinasab A, Ghasemi Zargar S, Sirous Kabiri S, et al. The regulating effect of Curcumin on NF-kappaB pathway in neurodegenerative diseases: a review of the underlying mechanisms. Inflammopharmacology. 2024;32(4):2125\u201351.","journal-title":"Inflammopharmacology"},{"issue":"2","key":"796_CR196","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1111\/acel.12185","volume":"13","author":"A Currais","year":"2014","unstructured":"Currais A, Prior M, Dargusch R, Armando A, Ehren J, Schubert D, et al. Modulation of p25 and inflammatory pathways by Fisetin maintains cognitive function in Alzheimer\u2019s disease Transgenic mice. Aging Cell. 2014;13(2):379\u201390.","journal-title":"Aging Cell"},{"issue":"4","key":"796_CR197","doi-asserted-by":"publisher","first-page":"1429","DOI":"10.3233\/JAD-170093","volume":"60","author":"JR Sundaram","year":"2017","unstructured":"Sundaram JR, Poore CP, Sulaimee NHB, Pareek T, Cheong WF, Wenk MR, et al. Curcumin ameliorates Neuroinflammation, Neurodegeneration, and memory deficits in p25 Transgenic mouse model that bears hallmarks of Alzheimer\u2019s disease. J Alzheimers Dis. 2017;60(4):1429\u201342.","journal-title":"J Alzheimers Dis"},{"key":"796_CR198","doi-asserted-by":"crossref","unstructured":"Krikorian R, Skelton MR, Summer SS, Shidler MD, Sullivan PG. Blueberry supplementation in midlife for dementia risk reduction. Nutrients. 2022;14(8).","DOI":"10.3390\/nu14081619"},{"issue":"10","key":"796_CR199","doi-asserted-by":"publisher","first-page":"1190","DOI":"10.1007\/s12603-021-1685-4","volume":"25","author":"W Yang","year":"2021","unstructured":"Yang W, Cui K, Li X, Zhao J, Zeng Z, Song R, et al. Effect of polyphenols on cognitive function: evidence from Population-Based studies and clinical trials. J Nutr Health Aging. 2021;25(10):1190\u2013204.","journal-title":"J Nutr Health Aging"},{"key":"796_CR200","doi-asserted-by":"crossref","unstructured":"De Bruyne T, Steenput B, Roth L, De Meyer GRY, Santos CND, Valentova K et al. Dietary polyphenols targeting arterial stiffness: interplay of contributing mechanisms and gut Microbiome-Related metabolism. Nutrients. 2019;11(3).","DOI":"10.3390\/nu11030578"}],"container-title":["Pharmacological Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s43440-025-00796-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s43440-025-00796-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s43440-025-00796-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,26]],"date-time":"2025-11-26T01:03:44Z","timestamp":1764119024000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s43440-025-00796-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,24]]},"references-count":200,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["796"],"URL":"https:\/\/doi.org\/10.1007\/s43440-025-00796-5","relation":{},"ISSN":["1734-1140","2299-5684"],"issn-type":[{"value":"1734-1140","type":"print"},{"value":"2299-5684","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,24]]},"assertion":[{"value":"27 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 October 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 October 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 October 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human ethics and consent to participate declarations"}},{"value":"The figure and the graphical abstract were created using CorelDRAW Graphics Suite for Windows.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Other information"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}